Showing 101 - 120 of 207 results
Beamline scientist
Role at ANSTO
The past, present and future in climate system science
Association recognises contribution to neutron scattering
International neutron scattering award for retired head of former Bragg Institute, Prof Robert Robinson
Radiocarbon dating supports Aboriginal occupation of South Australia for 29,000 years
Radiocarbon dating at ANSTO has supported research that vastly extends the known timeline of the Aboriginal occupation of South Australia’s Riverland region.
Senior Project Manager
Role at ANSTO
Senior Project Manager
Role at ANSTO
User Meeting 2024 - Awards & Prizes
You are invited to submit to the various awards from ANSTO and the User Meeting 2024 organising committee.
Laboratory Operations Manager, National Deuteration Facility
Role at ANSTO
Kookaburra (Ultra-Small-Angle Neutron Scattering)
Role at ANSTO
Accelerator Systems Overview
Sample Guide - XFM beamlime
Samples on the X-ray fluorescence microscopy beamline at the Australian Synchrotron.
Deuteration Research Facility Chemist. National Deuteration Facility
Rao graduated with BSc(chemistry), B.Pharm, M.Pharm (Pharmaceutical Chemistry) and then PhD in Organic Synthesis from University of Wollongong, NSW, Australia.
Radioanalytical chemistry
ANSTO’s Radioanalytical Chemistry (RAC) facility combines techniques in radiochemistry and radiological measurement by alpha spectrometry, gamma-ray spectrometry, and liquid scintillation analysis to deliver radiological assessments.
New beamline provides state-of-the-art imaging capability
The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.
ANSTO supports innovative industry process to minimise plastic waste and maximise feed stock for 3D printing
Radiochemist
Role at ANSTO
User Meeting 2025 - Awards & Prizes
You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee.
Nuclear technique improves properties of innovative bone implant material
A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.